Synlogic Inc (SYBX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Synlogic Inc (SYBX) has a cash flow conversion efficiency ratio of -0.078x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-923.00K) by net assets ($11.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Synlogic Inc stock valuation for the company's overall valuation and market capitalisation.
Synlogic Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Synlogic Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Synlogic Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Synlogic Inc ranked by their cash flow conversion efficiency. Explore Synlogic Inc (SYBX) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tokyo Lifestyle Co., Ltd.
NASDAQ:TKLF
|
-0.053x |
|
HEBEI YICHEN GRP H YC 05
F:HE2
|
N/A |
|
Enlitic Inc
AU:ENL
|
-0.698x |
|
Ace Oldfields PT
JK:KUAS
|
0.002x |
|
Armada Berjaya Trans Tbk PT
JK:JAYA
|
0.080x |
|
Slam Exploration Ltd.
V:SXL
|
-0.046x |
|
Lombard et Medot SA
PA:MLCAC
|
N/A |
|
Mcnally Bharat Engineering Company Limited
NSE:MBECL
|
0.000x |
Annual Cash Flow Conversion Efficiency for Synlogic Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Synlogic Inc from 2013 to 2025. View Synlogic Inc stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $11.86 Million | $-4.36 Million | -0.367x | +85.20% |
| 2024-12-31 | $12.75 Million | $-31.66 Million | -2.483x | -105.18% |
| 2023-12-31 | $42.66 Million | $-51.61 Million | -1.210x | -75.72% |
| 2022-12-31 | $82.61 Million | $-56.89 Million | -0.689x | -94.28% |
| 2021-12-31 | $147.27 Million | $-52.20 Million | -0.354x | -3.18% |
| 2020-12-31 | $115.14 Million | $-39.55 Million | -0.344x | +28.58% |
| 2019-12-31 | $156.91 Million | $-75.47 Million | -0.481x | -40.54% |
| 2018-12-31 | $124.10 Million | $-42.47 Million | -0.342x | +6.29% |
| 2017-12-31 | $85.04 Million | $-31.05 Million | -0.365x | +11.15% |
| 2016-12-31 | $60.35 Million | $-24.80 Million | -0.411x | -65.33% |
| 2015-12-31 | $85.02 Million | $-21.14 Million | -0.249x | -185.33% |
| 2014-12-31 | $-47.95 Million | $-13.97 Million | 0.291x | +34.16% |
| 2013-12-31 | $-29.91 Million | $-6.50 Million | 0.217x | -- |
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.